Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Inside Sales | Business Development Enterprise Software Are you looking to work for a reputable and established brand, in a new and exciting sales role, offering excellent commission opportunities, whilst being able to work in our